Biotech Performance Glance—and Promising Ripples for Recovery
A abstract of key takeaways from EY’s new Past Borders report.My colleagues at Ernst & Younger LLP (EY US) ...
Read moreTag: Biotech
3 Biotech Stocks That Sank in 2021 but Could Soar in 2022
There is no denying that 2021 has been a tough yr for a lot of biotech shares. The shares ...
Read more
